Patient-reported quality of life (QOL) following CTL019 in pediatric and young adult patients (pts) with relapsed/refractory (r/r) b-cell acute lymphoblastic leukemia (B-ALL).Andrew C. Dietz, Andrew C. Harris, Theodore W. Laetsch et al.|Journal of Clinical Oncology|2017Cited by 2